Bizarre Patents
An automatic bed maker which uses the expansion of inflatable bladder to straighten, align, and tuck-in bed-cover assembly.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120128766 | Self-Breaking Tablets Self-breaking core tablets and functionally coated tablets and capsule formulations are provided. Methods for production of these tablet and capsule formulations and their administration are also provided.... | 05/24/2012 |
| 20120128767 | THERAPEUTIC CALCIUM PHOSPHATE PARTICLES AND METHODS OF MAKING AND USING SAME The present invention provides novel calcium phosphate nanoparticles suitable for efficient encapsulation of biologically active molecules. The invention further provides pharmaceutical compositions comprising these nanoparticles, as well as methods of making such nanop... | 05/24/2012 |
| 20120082720 | Compositions For Treating Chronic Viral Infections The present invention describes dietary compositions and methods of using such compositions to treat chronic viral infections, including hepatitis B and hepatitis C infections.... | 04/05/2012 |
| 20120082722 | METHODS AND COMPOSITIONS FOR ORAL DELIVERY OF FTS Disclosed are oral dosage forms containing a Ras antagonist including FTS and structural analogs thereof, and at least one pharmaceutically acceptable excipient other than a cyclodextrin, and methods of orally administering same to treat diseases and disorders responsiv... | 04/05/2012 |
| 20120052121 | NEW COMBINATION OF ACTIVE INGREDIENTS CONTAINING A NON STEROIDAL ANTI INFLAMMATORY DRUG AND A COLCHICOSIDE DERIVATIVE Pharmaceutical composition containing a combination of a non steroidal anti inflammatory drug and a colchicoside derivative, the active ingredients being present in the free state or in the form of a salt.... | 03/01/2012 |
| 20120052122 | Treatment Of Chronic Obstructive Pulmonary Disease With Phosphodiesterase-4 Inhibitor Disclosed is a method of treatment of chronic obstructive pulmonary disease associated with chronic bronchitis in a patient at risk of exacerbations. The method includes administering to a patient with a history of chronic obstructive pulmonary disease associated with c... | 03/01/2012 |
| 20120045509 | MODIFIED RELEASE COMPOSITIONS FOR DPP-IV INHIBITORS The present invention refers to pharmaceutical composition comprising a DPP-IV inhibitor.... | 02/23/2012 |
| 20120045510 | TABLET SLEEVE FOR IMPROVED PERFORMANCE A capsule-like dosage form, method for producing such dosage form and apparatus are disclosed. Such dosage form is achieved by applying a sleeve over the caplet to provide a coating which is smoother and easier to swallow than an uncoated caplet. The production of the c... | 02/23/2012 |
| 20120034299 | COMPOSITIONS FOR THE TREATMENT OF GLUTEN INTOLERANCE AND USES THEREOF The present invention provides compositions for use in the prophylaxis or treatment of a condition arising from gluten intolerance, the compositions including at least partially purified caricain (or a biologically active fragment, analogue or variant thereof) alone or ... | 02/09/2012 |
| 20120027857 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING O-DESMETHYL-VENLAFAXINE This invention relates to sustained release pharmaceutical compositions comprising O-desmethyl-venlafaxine, in particular to sustained pharmaceutical compositions comprising O-desmethyl-venlafaxine orotate and/or O-desmethyl-venlafaxine glucuronate.... | 02/02/2012 |
| 20120027853 | PROCESS FOR PREPARATION OF ANTI-TUBERCULAR COMBINATION AND PHARMACEUTICAL COMPOSITION PREPARED THEREFROM This invention relates to a process for preparing a pharmaceutical composition comprising four antitubercular drugs: rifampin or a pharmaceutically acceptable salt thereof, isoniazid or a pharmaceutically acceptable salt thereof, pyrazinamide or a pharmaceutically accep... | 02/02/2012 |
| 20120027856 | PHARMACEUTICAL PRODUCT COMPRISING YEAST A pharmaceutical product containing an active pharmaceutical ingredient and having a controllable release of the active pharmaceutical ingredient. The pharmaceutical product comprises yeast that is capable of fermentation. The carbon dioxide production of the fermentati... | 02/02/2012 |
| 20120021029 | PEPTIDES USED IN THE TREATMENT AND/OR CARE OF THE SKIN AND/OR HAIR AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS Peptides of general formula (I):
its stereoisomers, mixtures thereof and/or their cosmeti... | 01/26/2012 |
| 20120015033 | ANTISENSE COMPOSITIONS AND METHODS OF MAKING AND USING SAME The present invention provides pharmaceutical formulations for oral administration of antisense oligonucleotides, such as antisense oligonucleotides against SMAD7. The pharmaceutical formulations can be used to treat Crohn's disease, ulcerative colitis and chronic infla... | 01/19/2012 |
| 20120015032 | COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME The present invention relates to a chronotherapeutically combined pharmaceutical formulation for preventing and treating cardiovascular diseases, which is based on the principle of administering a plurality of drugs at certain time intervals (chronotherapy). Specificall... | 01/19/2012 |
| 20120009256 | Treatment Including Prebiotic Composition for use with Probiotics Naturally occurring lecithins and/or oleic acid stimulate the growth and lactic acid producing activity of Lactobacillus and Bifidobacterium species of probiotic bacteria, and replace polysorbate 80 for those products. They can be used in naturally occurri... | 01/12/2012 |
| 20120003302 | PHARMACEUTICAL COMPOSITION CONTAINING A FERMENTED, DEHYDRATED MATERIAL WITH AMORPHOUS CRYSTALLINE STRUCTURE The invention concerns a high water soluble product, containing a dehydrated material, obtained by fermenting wheat germ in aqueous medium in the presence of microorganisms of the Saccharomyces genus, forming amorphous crystal structure with inert auxiliary materials), ... | 01/05/2012 |
| 20120003307 | LEVETIRACETAM CONTROLLED RELEASE COMPOSITION The present invention is concerned with controlled release compositions for oral administration comprising levetiracetam; and with processes of preparing such controlled release compositions.... | 01/05/2012 |
| 20120003313 | DPP IV INHIBITOR FORMULATIONS The present invention relates to pharmaceutical compositions of DPP IV inhibitors with an amino group, their preparation and their use to treat diabetes mellitus.... | 01/05/2012 |
| 20120003306 | Pharmaceutical composition of nanoparticles for protein drug delivery The invention discloses a pharmaceutical composition of bioactive nanoparticles composed of chitosan, poly-glutamic acid, and a bioactive agent for oral delivery. The chitosan-based nanoparticles are characterized with a positive surface charge and enhanced permeability... | 01/05/2012 |
| 20120003314 | DELAYED-RELEASE ORAL PHARMACEUTICAL COMPOSITION FOR TREATMENT OF COLONIC DISORDERS A timed or delayed release oral composition delivery system for the treatment of colonic disorders and diseases is provided. According to one aspect, a delayed release oral pharmaceutical composition includes an active core comprising a therapeutically effective amount ... | 01/05/2012 |
| 20110318409 | FRACTIONS OF WHEAT GERM FERMENT The invention concerns wheat germ ferment, its biologically active fractions, the process for their production, the pharmaceutical preparations containing them and their uses.... | 12/29/2011 |
| 20110311622 | METHOD FOR ADDING SENSORY CONDITIONING CUES IN A PHARMACOTHERAPEUTIC REGIMEN A method for administering pharmaceutical agents to a subject is provided. The method includes the steps of: a) providing a course of treatment for a subject, which course includes periodically administering an amount of medicine to the subject, which amount of medicine... | 12/22/2011 |
| 20110311621 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF DELVERY The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent (such as CCK-8, octreotide), at least one salt of a medium chain fatty acid, a matrix forming po... | 12/22/2011 |
| 20110305757 | NEW PHARMACEUTICAL COMBINATIONS A pharmaceutical composition including a compound of Formula I (Compound I) or pharmaceutically acceptable salts thereof and one or more diuretics as effective components, wherein said one or more diuretics are selected from thiazide derivatives. Methods for preparing t... | 12/15/2011 |
| 20110305758 | ORALLY DISINTEGRATING TABLET HAVING INNER CORE The present invention provides an orally disintegrating tablet with improved photostability of a medicament unstable to light. The orally disintegrating tablet has an inner core and an outer layer that covers the surface of the inner core, wherein the inner core contain... | 12/15/2011 |
| 20110300210 | CONTROLLED RELEASE NANOPARTICULATE CLOZAPINE COMPOSITIONS Described are controlled release nanoparticulate formulations comprising a nanoparticulate agent to be administered and a rate-controlling polymer which functions to prolong the release of the agent following administration. The novel compositions release the agent foll... | 12/08/2011 |
| 20110300213 | Oral formulations of bipolar trans carotenoids The subject invention relates to a variety of formulations of bipolar trans carotenoids including pharmaceutical compositions for oral delivery of a bipolar trans carotenoid comprising i) a bipolar trans carotenoid, ii) a cyclodextrin, and iii) a coating. The invention ... | 12/08/2011 |
| 20110293719 | NOVEL COMPOUNDS AND COMPOSITIONS AND METHODS OF USE Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels... | 12/01/2011 |
| 20110293711 | Utilization of Dialkylfumarates The present invention relates to the use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets. For this... | 12/01/2011 |
| 20110287091 | CHRONOTHERAPEUTIC PHARMACEUTICAL COMPOSITION The present invention relates to chronotherapeutic pharmaceutical compositions and a method of preparing the same. The composition comprises of at least one active ingredient, a pH independent agent and a hydrophilic agent. The active ingredient in the composition is co... | 11/24/2011 |
| 20110287100 | Galenic Formulations of Organic Compounds A solid unit dosage form of aliskiren for oral administration in the form of a tablet having a core and an outer coating is prepared such that the core contains a therapeutically effective amount of aliskiren and the outer coating is in the form of a film-coat with tast... | 11/24/2011 |
| 20110280941 | COMPOSITIONS OF PROTON PUMP INHIBITORS AND INSULIN SECRETAGOGUES, AND METHODS OF THEIR USE TO TREAT DIABETES The present invention relates to compositions, kits and methods of treating diabetes. More specifically, compositions of at least one proton pump inhibitor and at least one insulin secretagogue, kits and methods of their use to treat diabetes.... | 11/17/2011 |
| 20110274750 | ENTERIC FORMULATION OF DULOXETINE AND ITS CORE AND PREPRATION METHOD An enteric formulation of duloxetine, its core and preparing method thereof are disclosed. The core comprises duloxetine or its salt and pharmaceutically acceptable excipients. The excipients include water-soluble hot melt materials selected from PEG, poloxamer, polyoxy... | 11/10/2011 |
| 20110274753 | DUAL RELEASE ORAL TABLET COMPOSITIONS OF DEXLANSOPRAZOLE Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.... | 11/10/2011 |
| 20110268797 | MULTICOATED ALISKIREN FORMULATIONS An oral pharmaceutical formulation of aliskiren, or a pharmaceutically acceptable salt or polymorph thereof, having at least two coating layers.... | 11/03/2011 |
| 20110268801 | NOVEL COMPOUNDS AND COMPOSITIONS AND METHODS OF USE Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels... | 11/03/2011 |
| 20110268800 | Unsaturated fatty acids as thrombin inhibitors A preparation having at least one unsaturated fatty acid and the use of at least one unsaturated fatty acid having a chain length of 18 or 20 carbon atoms and of plant drugs containing the unsaturated fatty acid as a free fatty acid or a fatty acid radical of a triglyce... | 11/03/2011 |
| 20110262540 | Solid Pharmaceutical Composition Comprising Exemestane A solid pharmaceutical composition of exemestane, in particular for oral use and treatment of cancer, comprises micronized exemestane and anti-oxidant in a film-coated tablet.... | 10/27/2011 |
| 20110256221 | PHARMACEUTICAL FORMULATIONS OF OLMESARTAN This invention is related to pharmaceutical compositions, which have good flowability properties, comprising olmesartan medoxomil or combination of olmesartan medoxomil and hydrochlorothiazide and a lubricant or mixtures of lubricants and a pharmaceutically acceptable e... | 10/20/2011 |
